Skip to main navigation Skip to search Skip to main content

Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study

  • Dana M. Chase
  • , Michael W. Sill
  • , Bradley J. Monk
  • , Mark D. Chambers
  • , Kathleen M. Darcy
  • , Ernest S. Han
  • , Barbara J. Buening
  • , Joel I. Sorosky
  • , John P. Fruehauf
  • , Robert A. Burger*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry

Immunology and Microbiology